On November 20th, 2012 Pharmaceutical Business Review published that Astellas Pharma seeks US FDA approval for its drug Tarceva to treat non-small cell lung cancer patients (NSCLC). Tarceva, sold by...
(PRWeb November 28, 2012)
Read the full story at http://www.prweb.com/releases/2012/11/prweb10168097.htm